prof. dr. Pieter Van Vlierberghe

Journal Article
A1
open access

Myb drives B-cell neoplasms and myeloid malignancies in vivo

Tim Pieters (UGent) , André Pedro Pinto De Almeida (UGent) , Sara T'Sas (UGent) , Kelly Lemeire (UGent) , Tino Hochepied (UGent) , Geert Berx (UGent) , Alex Kentsis, Steven Goossens (UGent) and Pieter Van Vlierberghe (UGent)

(2022) BLOOD ADVANCES. 6(10). p.2987-2991

Add to list

Journal Article
A1
open access

Novel insights on the use of L-asparaginase as an efficient and safe anti-cancer therapy

Maaike Van Trimpont (UGent) , Evelien Peeters (UGent) , Yanti De Visser (UGent) , Amanda M. Schalk, Veerle Mondelaers (UGent) , Barbara De Moerloose (UGent) , Arnon Lavie, Tim Lammens (UGent) , Steven Goossens (UGent) and Pieter Van Vlierberghe (UGent)

(2022) CANCERS. 14(4).

Add to list

Journal Article
A1
open access

Direct and indirect anti-leukemic properties of Activity-on-Target interferons for the treatment of T-cell acute lymphoblastic leukemia

Steven Goossens (UGent) , Anje Cauwels (UGent) , Tim Pieters (UGent) , Renate De Smedt (UGent) , Sara T'Sas (UGent) , André Pedro Pinto De Almeida (UGent) , Willem Daneels (UGent) , Pieter Van Vlierberghe (UGent) and Jan Tavernier (UGent)

(2022) HAEMATOLOGICA. 107(6). p.1448-1453

Add to list

SOX11 functions as an oncogene in Lmo2-driven T-cell lymphoblastic leukemia (T-ALL)

André Pedro Pinto De Almeida (UGent) , Tim Pieters (UGent) , Sara T'Sas (UGent) , Steven Goossens (UGent) and Pieter Van Vlierberghe (UGent)

(2021) BLOOD. In Blood 138(Supplement 1). p.1136-1137

Add to list

Journal Article
A1
open access

Unlike its paralog LEDGF/p75, HRP-2 is dispensable for MLL-R leukemogenesis but important for leukemic cell survival

Siska Van Belle, Sara El Ashkar, Kateřina Čermáková, Filip Matthijssens (UGent) , Steven Goossens (UGent) , Alessandro Canella, Courtney H. Hodges, Frauke Christ, Jan De Rijck, Pieter Van Vlierberghe (UGent) , et al.

(2021) CELLS. 10(1).

Add to list

Journal Article
A1
open access

Phosphocatalytic kinome activity profiling of apoptotic and ferroptotic agents in multiple myeloma cells

Emilie Logie, Claudina Perez Novo, Amber Driesen, Pieter Van Vlierberghe (UGent) and Wim Vanden Berghe

(2021) INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 22(23).

Add to list

T-ALL can evolve to oncogene independence

Hesham Abdulla, Anh Vo, Benjamin J. Shields, Tenae J. Davies, Jacob T. Jackson, Raed Alserihi, Elizabeth M. Viney, Tin Wong, Feng Yan, Nicholas C. Wong, et al.

(2021) LEUKEMIA. 35(8). p.2205-2219

Add to list

Journal Article
A1
open access

Alternative glycosylation controls endoplasmic reticulum dynamics and tubular extension in mammalian cells

Despoina Kerselidou, Bushra Saeed Dohai, David R. Nelson, Sarah Daakour, Nicolas De Cock, Zahra Al Oula Hassoun, Dae-Kyum Kim, Julien Olivet, Diana C. El Assal, Ashish Jaiswal, et al.

(2021) SCIENCE ADVANCES. 7(19).

Add to list

Journal Article
A1
open access

T-BET and EOMES accelerate and enhance functional differentiation of human natural killer cells

Laura Kiekens (UGent) , Wouter Van Loocke (UGent) , Sylvie Taveirne (UGent) , Sigrid Wahlen (UGent) , Eva Persyn (UGent) , Els Van Ammel (UGent) , Zenzi De Vos (UGent) , Patrick Matthys, Filip Van Nieuwerburgh (UGent) , Tom Taghon (UGent) , et al.

(2021) FRONTIERS IN IMMUNOLOGY. 12.

Add to list

Journal Article
A1
open access

Cyclin D2 overexpression drives B1a-derived MCL-like lymphoma in mice

Tim Pieters (UGent) , Sara T'Sas (UGent) , Stijn Vanhee (UGent) , André Pedro Pinto De Almeida (UGent) , Yasmine Driege (UGent) , Juliette Roels (UGent) , Wouter Van Loocke (UGent) , Willem Daneels (UGent) , Mathijs Baens, Arnaud Marchand, et al.

(2021) JOURNAL OF EXPERIMENTAL MEDICINE. 218(10).

Academic Bibliography

prof. dr. Pieter Van Vlierberghe

Myb drives B-cell neoplasms and myeloid malignancies in vivo

Novel insights on the use of L-asparaginase as an efficient and safe anti-cancer therapy

Direct and indirect anti-leukemic properties of Activity-on-Target interferons for the treatment of T-cell acute lymphoblastic leukemia

SOX11 functions as an oncogene in Lmo2-driven T-cell lymphoblastic leukemia (T-ALL)

Unlike its paralog LEDGF/p75, HRP-2 is dispensable for MLL-R leukemogenesis but important for leukemic cell survival

Phosphocatalytic kinome activity profiling of apoptotic and ferroptotic agents in multiple myeloma cells

T-ALL can evolve to oncogene independence

Alternative glycosylation controls endoplasmic reticulum dynamics and tubular extension in mammalian cells

T-BET and EOMES accelerate and enhance functional differentiation of human natural killer cells

Cyclin D2 overexpression drives B1a-derived MCL-like lymphoma in mice

Contents

Support

Contact